Skip to main content
. 2005 May 24;388(Pt 2):475–483. doi: 10.1042/BJ20041314

Figure 4. Cardiac hypertrophy by high doses of H11 is unmasked by caspase 3 inhibitor treatment.

Figure 4

Myocytes were transduced with Ad-LacZ or Ad-H11 at MOI=100 (A) or at the indicated MOI (B, C); 12 h after transduction, myocytes were incubated with or without DEVD-CHO (150 μM) for 48 h. (A) Phase-contrast microscope images. NT, no transduction. (B) Results of Cell Death ELISAs are shown. The A405 (OD405) in untransduced myocytes was designated as 1.0. Results are representative of three experiments performed in duplicate. (C) Total protein content/DNA content was determined from three experiments performed in triplicate each. The data from myocytes without adenovirus transduction or DEVD-CHO (white bar) were designated as 1.0. NT, no transduction. *P<0.001 versus NT.